tiprankstipranks
Knight Therapeutics (TSE:GUD)
TSX:GUD
Canadian Market
GUD
Knight Therapeutics
RESEARCH TOOLSreports

Knight Therapeutics (GUD) Ratios

109 Followers

Knight Therapeutics Ratios

TSE:GUD's free cash flow for Q4 2025 was C$0.38. For the 2025 fiscal year, TSE:GUD's free cash flow was decreased by C$ and operating cash flow was C$0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.39 2.39 3.57 3.20 2.80
Quick Ratio
 1.57 1.57 2.64 2.40 2.14
Cash Ratio
 0.46 0.46 0.72 0.52 0.51
Solvency Ratio
 0.18 0.18 0.34 0.17 0.14
Operating Cash Flow Ratio
 0.42 0.43 0.33 0.32 0.29
Short-Term Operating Cash Flow Coverage
 3.42 3.49 2.07 2.01 2.29
Net Current Asset Value
C$ 115.81MC$ 115.81MC$ 228.12MC$ 166.49MC$ 166.64M
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.07 0.05 0.07 0.07
Debt-to-Equity Ratio
 0.10 0.10 0.06 0.09 0.09
Debt-to-Capital Ratio
 0.09 0.09 0.06 0.08 0.09
Long-Term Debt-to-Capital Ratio
 0.06 0.06 0.03 0.06 0.06
Financial Leverage Ratio
 1.36 1.36 1.21 1.27 1.28
Debt Service Coverage Ratio
 1.72 1.82 2.50 1.52 1.62
Interest Coverage Ratio
 -0.23 -0.21 0.80 -0.23 -0.36
Debt to Market Cap
 0.09 0.12 0.08 0.11 0.12
Interest Debt Per Share
 0.89 0.89 0.58 0.76 0.73
Net Debt to EBITDA
 0.03 0.03 -0.48 0.25 0.24
Profitability Margins
Gross Profit Margin
37.98%33.49%46.97%46.51%47.03%
EBIT Margin
-1.16%-0.49%3.04%-2.89%-12.73%
EBITDA Margin
11.41%12.08%17.34%12.46%8.60%
Operating Profit Margin
-0.52%-0.49%1.99%-0.88%-0.82%
Pretax Profit Margin
-1.49%-1.49%0.55%-6.70%-14.97%
Net Profit Margin
-1.19%-1.19%1.17%-5.13%-10.18%
Continuous Operations Profit Margin
-1.19%-1.19%1.17%-5.13%-10.18%
Net Income Per EBT
80.19%80.19%211.11%76.56%68.00%
EBT Per EBIT
285.19%304.50%27.74%760.83%1829.38%
Return on Assets (ROA)
-0.51%-0.51%0.45%-1.78%-2.83%
Return on Equity (ROE)
-0.70%-0.70%0.54%-2.25%-3.62%
Return on Capital Employed (ROCE)
-0.27%-0.25%0.87%-0.35%-0.26%
Return on Invested Capital (ROIC)
-0.21%-0.20%0.85%-0.26%-0.17%
Return on Tangible Assets
-0.93%-0.93%0.73%-2.92%-4.72%
Earnings Yield
-0.72%-0.89%0.80%-3.02%-5.02%
Efficiency Ratios
Receivables Turnover
 3.26 3.26 3.27 3.34 2.70
Payables Turnover
 2.31 2.48 2.51 2.06 1.47
Inventory Turnover
 2.05 2.20 1.92 1.91 1.68
Fixed Asset Turnover
 20.53 20.53 18.54 18.38 12.97
Asset Turnover
 0.43 0.43 0.39 0.35 0.28
Working Capital Turnover Ratio
 1.88 1.75 1.38 1.30 1.29
Cash Conversion Cycle
 131.71 130.39 156.75 122.69 103.13
Days of Sales Outstanding
 112.10 112.10 111.61 109.24 134.98
Days of Inventory Outstanding
 177.66 165.67 190.38 190.94 217.09
Days of Payables Outstanding
 158.05 147.38 145.23 177.49 248.95
Operating Cycle
 289.76 277.77 301.98 300.19 352.08
Cash Flow Ratios
Operating Cash Flow Per Share
 0.69 0.71 0.36 0.33 0.35
Free Cash Flow Per Share
 0.39 0.69 0.05 0.24 0.13
CapEx Per Share
 0.30 0.02 0.31 0.09 0.22
Free Cash Flow to Operating Cash Flow
 0.57 0.97 0.13 0.72 0.36
Dividend Paid and CapEx Coverage Ratio
 2.31 36.85 1.15 3.61 1.57
Capital Expenditure Coverage Ratio
 2.31 36.85 1.15 3.61 1.57
Operating Cash Flow Coverage Ratio
 0.88 0.90 0.73 0.52 0.52
Operating Cash Flow to Sales Ratio
 0.15 0.16 0.10 0.11 0.14
Free Cash Flow Yield
5.22%11.35%0.89%4.66%2.46%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -141.20 -112.09 124.55 -33.13 -19.91
Price-to-Sales (P/S) Ratio
 1.69 1.34 1.45 1.70 2.03
Price-to-Book (P/B) Ratio
 0.99 0.79 0.68 0.75 0.72
Price-to-Free Cash Flow (P/FCF) Ratio
 19.46 8.81 112.22 21.47 40.58
Price-to-Operating Cash Flow Ratio
 11.03 8.57 14.87 15.52 14.70
Price-to-Earnings Growth (PEG) Ratio
 2.46 0.50 -0.98 0.86 0.07
Price-to-Fair Value
 0.99 0.79 0.68 0.75 0.72
Enterprise Value Multiple
 14.82 11.11 7.90 13.89 23.80
Enterprise Value
 749.11M 603.84M 508.91M 568.08M 601.15M
EV to EBITDA
 14.59 11.11 7.90 13.89 23.80
EV to Sales
 1.66 1.34 1.37 1.73 2.05
EV to Free Cash Flow
 19.19 8.83 105.85 21.87 40.99
EV to Operating Cash Flow
 10.89 8.59 14.03 15.81 14.85
Tangible Book Value Per Share
 3.00 2.99 4.21 3.51 3.52
Shareholders’ Equity Per Share
 7.74 7.71 7.87 6.95 7.19
Tax and Other Ratios
Effective Tax Rate
 0.20 0.20 -1.11 0.23 0.32
Revenue Per Share
 4.54 4.52 3.67 3.05 2.56
Net Income Per Share
 -0.05 -0.05 0.04 -0.16 -0.26
Tax Burden
 0.80 0.80 2.11 0.77 0.68
Interest Burden
 1.28 3.04 0.18 2.31 1.18
Research & Development to Revenue
 0.06 0.06 0.06 0.05 0.05
SG&A to Revenue
 0.28 0.28 0.27 0.11 0.14
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 <0.01
Income Quality
 -12.80 -13.08 8.37 -2.13 -1.35
Currency in CAD